Trial Outcomes & Findings for Investigation of Three Newly Developed 2-piece Convex Base-plates in Subjects With Ileostomy (NCT NCT01957397)

NCT ID: NCT01957397

Last Updated: 2016-09-30

Results Overview

The degree of leakage was measured with a 32 -point scale developed by Coloplast A/S, where 0 is the best possible outcome (no leakage) and 32 is the worst possible outcome (full leakage under the baseplate)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

26 participants

Primary outcome timeframe

14 days

Results posted on

2016-09-30

Participant Flow

Subjects are recruited from the Coloplast A/S user database in Denmark.

The subjects are randomised to two arms In both arms the subjects start measuring the performance of own product to collect baseline data. In this arm the subjects are randomised between Coloplast Test1 and Coloplast Test 2 In the third test period all subject test Coloplast Test 3

Participant milestones

Participant milestones
Measure
1st Coloplast Test 1,2nd Coloplast Test 2 3rd Coloplast Test 3
The subjects are randomised to two arms In both arms the subjects start measuring the performance of own product to collect baseline data. In this arm the subjects are randomised to test Coloplast Test1 first and thereafter Coloplast Test 2 Finally the all subject test Coloplast Test 3 Coloplast Test 1: Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance Coloplast Test 2: Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance Coloplast Test 3: Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance
1st Coloplast Test 2 2nd Coloplast Test 1 3rd Coloplast Test 3
The subjects are randomised to two arms In both arms the subjects start measuring the performance of own product to collect baseline data. In this arm the subjects are randomised to test Coloplast Test 2 first and thereafter Coloplast Test 1 Finally the all subject test Coloplast Test 3 Coloplast Test 1: Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance Coloplast Test 2: Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance Coloplast Test 3: Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance
Baseline Own Product
STARTED
13
13
Baseline Own Product
COMPLETED
13
13
Baseline Own Product
NOT COMPLETED
0
0
Test Period 1
STARTED
13
13
Test Period 1
COMPLETED
11
12
Test Period 1
NOT COMPLETED
2
1
Test Period 2
STARTED
11
12
Test Period 2
COMPLETED
11
11
Test Period 2
NOT COMPLETED
0
1
Test Period 3
STARTED
11
11
Test Period 3
COMPLETED
9
9
Test Period 3
NOT COMPLETED
2
2

Reasons for withdrawal

Reasons for withdrawal
Measure
1st Coloplast Test 1,2nd Coloplast Test 2 3rd Coloplast Test 3
The subjects are randomised to two arms In both arms the subjects start measuring the performance of own product to collect baseline data. In this arm the subjects are randomised to test Coloplast Test1 first and thereafter Coloplast Test 2 Finally the all subject test Coloplast Test 3 Coloplast Test 1: Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance Coloplast Test 2: Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance Coloplast Test 3: Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance
1st Coloplast Test 2 2nd Coloplast Test 1 3rd Coloplast Test 3
The subjects are randomised to two arms In both arms the subjects start measuring the performance of own product to collect baseline data. In this arm the subjects are randomised to test Coloplast Test 2 first and thereafter Coloplast Test 1 Finally the all subject test Coloplast Test 3 Coloplast Test 1: Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance Coloplast Test 2: Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance Coloplast Test 3: Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance
Test Period 1
sudden leakage/small bag
1
1
Test Period 1
Withdrawal by Subject
1
0
Test Period 2
Adverse Event
0
1
Test Period 3
Adverse Event
1
2
Test Period 3
the adhesive did not work
1
0

Baseline Characteristics

Investigation of Three Newly Developed 2-piece Convex Base-plates in Subjects With Ileostomy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Overall Population
n=26 Participants
Age, Continuous
62.3 years
STANDARD_DEVIATION 10.4 • n=5 Participants
Sex: Female, Male
Female
17 Participants
n=5 Participants
Sex: Female, Male
Male
9 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 14 days

The degree of leakage was measured with a 32 -point scale developed by Coloplast A/S, where 0 is the best possible outcome (no leakage) and 32 is the worst possible outcome (full leakage under the baseplate)

Outcome measures

Outcome measures
Measure
Coloplast Test 1
n=146 baseplates
The subjects are randomised to two arms In both arms the subjects start measuring the performance of own product to collect baseline data. In this arm the subjects are randomised to test Coloplast Test1 first and thereafter Coloplast Test 2 Finally the all subject test Coloplast Test 3 Coloplast Test 1: Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance Coloplast Test 2: Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance Coloplast Test 3: Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance
Coloplast Test 2
n=146 baseplates
The subjects are randomised to two arms In both arms the subjects start measuring the performance of own product to collect baseline data. In this arm the subjects are randomised to test Coloplast Test 2 first and thereafter Coloplast Test 1 Finally the all subject test Coloplast Test 3 Coloplast Test 1: Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance Coloplast Test 2: Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance Coloplast Test 3: Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance
Coloplast Test 3
n=118 baseplates
Coloplast Test 3: Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance
Baseline - Own Product
n=166 baseplates
The subjects test own product to measure their baseline leakage
Degree of Leakage
4.5 units on a scale
Standard Deviation 4.9
5.2 units on a scale
Standard Deviation 4.8
6.4 units on a scale
Standard Deviation 5.5
6.8 units on a scale
Standard Deviation 6.0

Adverse Events

Coloplast Test 1

Serious events: 0 serious events
Other events: 7 other events
Deaths: 0 deaths

Coloplast Test 2

Serious events: 1 serious events
Other events: 15 other events
Deaths: 0 deaths

Coloplast Test 3

Serious events: 0 serious events
Other events: 12 other events
Deaths: 0 deaths

Baseline - Own Product

Serious events: 1 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Coloplast Test 1
n=25 participants at risk
Coloplast Test 1: Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance
Coloplast Test 2
n=24 participants at risk
Coloplast Test 2: Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance
Coloplast Test 3
n=22 participants at risk
Coloplast Test 3: Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance
Baseline - Own Product
n=26 participants at risk
The subjects test own product to measure their baseline leakage
Gastrointestinal disorders
Expantion of rectal stenosis
0.00%
0/25 • October - December 2012
4.2%
1/24 • Number of events 1 • October - December 2012
0.00%
0/22 • October - December 2012
0.00%
0/26 • October - December 2012
Cardiac disorders
Heart spams
0.00%
0/25 • October - December 2012
0.00%
0/24 • October - December 2012
0.00%
0/22 • October - December 2012
3.8%
1/26 • Number of events 1 • October - December 2012

Other adverse events

Other adverse events
Measure
Coloplast Test 1
n=25 participants at risk
Coloplast Test 1: Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance
Coloplast Test 2
n=24 participants at risk
Coloplast Test 2: Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance
Coloplast Test 3
n=22 participants at risk
Coloplast Test 3: Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance
Baseline - Own Product
n=26 participants at risk
The subjects test own product to measure their baseline leakage
Skin and subcutaneous tissue disorders
skin irritation
12.0%
3/25 • Number of events 3 • October - December 2012
33.3%
8/24 • Number of events 8 • October - December 2012
31.8%
7/22 • Number of events 7 • October - December 2012
3.8%
1/26 • Number of events 1 • October - December 2012
Skin and subcutaneous tissue disorders
Itching of peristomal skin
24.0%
6/25 • Number of events 6 • October - December 2012
12.5%
3/24 • Number of events 3 • October - December 2012
13.6%
3/22 • Number of events 3 • October - December 2012
0.00%
0/26 • October - December 2012
Skin and subcutaneous tissue disorders
Pain in the peristomal skin
0.00%
0/25 • October - December 2012
8.3%
2/24 • Number of events 2 • October - December 2012
13.6%
3/22 • Number of events 3 • October - December 2012
3.8%
1/26 • Number of events 1 • October - December 2012
Skin and subcutaneous tissue disorders
Broken skin in peristomal area
0.00%
0/25 • October - December 2012
8.3%
2/24 • Number of events 2 • October - December 2012
9.1%
2/22 • Number of events 2 • October - December 2012
3.8%
1/26 • Number of events 1 • October - December 2012

Additional Information

Birte Petersen Jakobsen, MD

Coloplast A/S

Phone: +45 4911 1395

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place